Alphabet Verily stops Smart Lens, glucose-measuring contact lens

Verily, Alphabet‘s life sciences arm, has paused work on its so-called “smart lens” program, which was aiming to put tiny sensors on contact lenses to measure blood sugar levels in tears.

If it worked, the lenses could help diabetics track their glucose levels in real time and in less invasive ways than the traditional meters that require piercing the skin. But in a blog post on Friday, Verily said that after four years of research it has determined that detecting blood sugar in tears is a massive — and potentially insurmountable — technical and scientific undertaking.

“Our clinical work on the glucose-sensing lens demonstrated that there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device,” the company said.

Leave a Reply

Your email address will not be published. Required fields are marked *